PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Treating HIV-infected people with antiretrovirals significantly reduces transmission to partners

Findings result from NIH-funded international study

2011-05-13
(Press-News.org) Men and women infected with HIV reduced the risk of transmitting the virus to their sexual partners by taking oral antiretroviral medicines when their immune systems were relatively healthy, according to findings from a large-scale clinical study sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

The clinical trial, known as HPTN 052, was slated to end in 2015 but the findings are being released early as the result of a scheduled interim review of the study data by an independent data and safety monitoring board (DSMB). The DSMB concluded that it was clear that use of antiretrovirals by HIV-infected individuals with relatively healthier immune systems substantially reduced transmission to their partners. The results are the first from a major randomized clinical trial to indicate that treating an HIV-infected individual can reduce the risk of sexual transmission of HIV to an uninfected partner.

"Previous data about the potential value of antiretrovirals in making HIV-infected individuals less infectious to their sexual partners came largely from observational and epidemiological studies," said NIAID Director Anthony S. Fauci, M.D. "This new finding convincingly demonstrates that treating the infected individual—and doing so sooner rather than later—can have a major impact on reducing HIV transmission."

Led by study chair Myron Cohen, M.D., director of the Institute for Global Health and Infectious Diseases at the University of North Carolina at Chapel Hill, HPTN 052 began in April 2005 and enrolled 1,763 couples, all at least 18 years of age. The vast majority of the couples (97 percent) were heterosexual, which precludes any definitive conclusions about effectiveness in men who have sex with men. The study was conducted at 13 sites in Botswana, Brazil, India, Kenya, Malawi, South Africa, Thailand, the United States and Zimbabwe. The U.S. site collected only limited data because of difficulties enrolling participants into the study. However, data from one serodiscordant couple at the site was included in the DSMB's analysis. At the time of enrollment, the HIV-infected partners (890 men, 873 women) had CD4+ T-cell levels—a key measure of immune system health—between 350 and 550 cells per cubic millimeter (mm³) within 60 days of entering the study. The HIV-uninfected partners had tested negative for the virus within 14 days of entering the study.

The investigators randomly assigned the couples to either one of two study groups. In the first group, the HIV-infected partner immediately began taking a combination of three antiretroviral drugs. In the second group (the deferred group), the HIV-infected partners began antiretroviral therapy when their CD4 counts fell below 250 cells/mm³ or an AIDS-related event, such as Pneumocystis pneumonia, occurred. Throughout the study, both groups received HIV-related care that included counseling on safe sex practices, free condoms, treatment for sexually transmitted infections, regular HIV testing, and frequent evaluation and treatment for any complications related to HIV infection. Each group received the same amount of care and counseling.

In its review, the DSMB found a total of 39 cases of HIV infection among the previously uninfected partners. Of those, 28 were linked through genetic analysis to the HIV-infected partner as the source of infection. Seven infections were not linked to the HIV-infected partner, and four infections are still undergoing analysis. Of the 28 linked infections, 27 infections occurred among the 877 couples in which the HIV-infected partner did not begin antiretroviral therapy immediately. Only one case of HIV infection occurred among those couples where the HIV-infected partner began immediate antiretroviral therapy. This finding was statistically significant and means that earlier initiation of antiretrovirals led to a 96 percent reduction in HIV transmission to the HIV-uninfected partner. The infections were confirmed by genetic analysis of viruses from both partners.

Additionally, 17 cases of extrapulmonary tuberculosis occurred in the HIV-infected partners in the deferred treatment arm compared with three cases in the immediate treatment arm, a statistically significant difference. There were also 23 deaths during the study. Ten occurred in the immediate treatment group and 13 in the deferred treatment group, a difference that did not reach statistical significance.

The study was designed to evaluate whether antiretroviral use by the HIV-infected individual reduced HIV transmission to the uninfected partner and potentially benefited the HIV-infected individual as well. Additionally, the study was designed to evaluate the optimal time for a person infected with HIV to initiate antiretrovirals in order to reduce HIV-related sickness and death. Based on their analysis, the DSMB recommended that the deferred study arm be discontinued and that the study participants be informed of the trial's outcome.

"We want to thank the study participants for making such an important contribution in the fight against HIV/AIDS. We think that these results will be important to help improve both HIV treatment and prevention," said Dr. Cohen.

Study participants are being informed of the results. Individuals who became HIV-infected during the course of the study were referred to local services for appropriate medical care and treatment. HIV-infected participants in the deferred treatment group will be offered antiretroviral therapy. The study investigators will continue following the study participants for at least one year.

The study was conducted by the HIV Prevention Trials Network, which is largely funded by NIAID with additional funding from the National Institute on Drug Abuse and the National Institute of Mental Health, both part of the NIH. Additional support was provided by the NIAID-funded AIDS Clinical Trials Group. The antiretroviral drugs used in the study were made available by Abbott Laboratories, Boehringer Ingelheim Pharmaceuticals, Inc., Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline/Viiv Healthcare and Merck & Co., Inc.

The 11 HIV drugs that were used in various combinations included the following:

atazanavir (300 mg once daily)
didanosine (400 mg once daily)
efavirenz (600 mg once daily)
emtricitabine/tenofovir disoproxil fumarate (200 mg emtricitabine/300 mg tenofovir disoproxil fumarate once daily)
lamivudine (300 mg once daily)
lopinavir/ritonavir 800/200 mg once daily (QD) or lopinavir/ritonavir 400/100 mg twice daily (BID)
nevirapine (200 mg taken once daily for 14 days followed by 200 mg taken twice daily)
ritonavir (100 mg once daily, used only to boost atazanavir)
stavudine (weight-dependent dosage)
tenofovir disoproxil fumarate (300 mg once daily)
zidovudine/lamivudine (150 mg lamivudine/300 mg zidovudine taken orally twice daily)

In an ongoing international clinical study called Strategic Timing of Antiretroviral Therapy (http://www.niaid.nih.gov/news/newsreleases/2011/Pages/START.aspx), NIAID is examining the optimal time for asymptomatic HIV-infected individuals to begin antiretrovirals.

### For additional information about the HPTN 052 study, see the Questions and Answers (http://www.niaid.nih.gov/news/QA/Pages/HPTN052qa.aspx) . Visit the NIAID HIV/AIDS Web portal (http://www.niaid.nih.gov/topics/hivaids/Pages/Default.aspx) for more information about NIAID's HIV/AIDS research.

NIAID conducts and supports research—at NIH, throughout the United States, and worldwide—to study the causes of infectious and immune-mediated diseases, and to develop better means of preventing, diagnosing and treating these illnesses. News releases, fact sheets and other NIAID-related materials are available on the NIAID website at www.niaid.nih.gov.

About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit www.nih.gov.


ELSE PRESS RELEASES FROM THIS DATE:

UNC-led study shows early treatment with antiretroviral therapy prevents HIV transmission

2011-05-13
CHAPEL HILL, NC — A research study led by the University of North Carolina at Chapel Hill has made a major discovery in the effort to halt the spread of HIV, the virus that causes AIDS. The study results show that early initiation of antiretroviral treatment in people infected with HIV prevents them from transmitting the virus to their partners. The study, known as HPTN 052, was designed to evaluate whether antiretroviral drugs can prevent sexual transmission of HIV infection among couples in which one partner is HIV-infected and the other is not. The results are ...

SC Supreme Court Issues Order to Counties to Expedite DUI/DUAC Dockets

2011-05-13
South Carolina drunk driving charges are a serious matter. In addition to a criminal record, motorists charged with and convicted of driving under the influence (DUI) face up to a month in jail and nearly $1,000 in fines. And those are just the criminal consequences, because a DUI record will also result in higher insurance rates, license suspension of up to six months and notoriety within an offender's community and at work. But like any other criminal justice process, drivers accused of DUI or driving with an unlawful alcohol concentration (DUAC) are entitled to due ...

Expectant fathers should receive prenatal care, support, study finds

Expectant fathers should receive prenatal care, support, study finds
2011-05-13
COLUMBIA, Mo. –A University of Missouri researcher has found that stress related to pregnancy uniquely affects the health of expectant fathers, which in turn, influences the health of expectant mothers and their infants. Health services should incorporate counseling and assessments for men and women to reduce stressors and promote positive pregnancy outcomes, says ManSoo Yu, assistant professor in MU's Public Health Program. Mental distress in pregnant women – caused by anxiety, lack of social support or low self-esteem – is associated with poor infant health. The importance ...

Passage of Ashley's Law Requires Sirens for Emergency Vehicles Responding to Calls

2011-05-13
A law inspired by the 2008 death of 33-year-old Ashley McIntosh now requires that Virginia police vehicles, fire trucks and ambulances responding to emergency calls not only have their so-called "blue lights" flashing but that they also activate their sirens and use their horns while crossing intersections. McIntosh was fatally injured by a Fairfax County officer on February 12, 2008 when Perry's police cruiser went through a red light -- with emergency lights flashing but without the siren turned on -- along U.S. Route 1 in Hybla Valley and struck McIntosh's ...

Strong, tough and now cheap: Caltech researchers develop a new way to process metallic glass

Strong, tough and now cheap: Caltech researchers develop a new way to process metallic glass
2011-05-13
PASADENA, Calif.—Stronger than steel or titanium—and just as tough—metallic glass is an ideal material for everything from cell-phone cases to aircraft parts. Now, researchers at the California Institute of Technology (Caltech) have developed a new technique that allows them to make metallic-glass parts utilizing the same inexpensive processes used to produce plastic parts. With this new method, they can heat a piece of metallic glass at a rate of a million degrees per second and then mold it into any shape in just a few milliseconds. "We've redefined how you process ...

Pennsylvania May Require DNA Samples For All Felony Arrests

2011-05-13
Legislation has been introduced that would require suspects charged with felonies and some misdemeanors to be swabbed for DNA samples in Pennsylvania. The bill is expected to move rapidly through the legislative process. Prosecutors favor the move as making it easier to obtain convictions. The present law limits DNA samples to those convicted or where permitted by a search warrant. The Pittsburg Tribune-Review quotes Sgt. Joe Gannon, from the Pittsburg police sex assault squad, and he explained that as evidence, it could go either way, "I think it's a good ...

Interactive teaching methods double learning in undergraduate physics class: UBC research

2011-05-13
Interactive teaching methods significantly improved attendance and doubled both engagement and learning in a large physics class, according to a University of British Columbia study published today in Science. Led by Louis Deslauriers, a post-doctoral researcher at UBC's Carl Wieman Science Education Initiative (CWSEI), the study compared the amount of learning students experienced when taught – in three hours over one week – by traditional lecture and by using interactive activities based on research in cognitive psychology and physics education. The research team ...

Scottsboro Hotel Near Goose Pond Colony Offers Convenient Lodging to Guests Attending Men's National Jr. College Golf Championship

2011-05-13
Hampton Inn & Suites Hotel Scottsboro offers nearby lodging to golfers and fans attending the National Junior College Athletic Association (NJAA) Division II Men's Golf Championship. The tournament will take place on Tuesday, May 17 at Goose Pond Colony Golf Course and will feature the best young golfers from across the country. Colleges that participate in Division II NJCC Golf are located across the country. Goose Pond Colony is a municipally owned resort located on the banks of the Tennessee River at Lake Guntersville, Alabama's largest lake. Goose Pond Colony ...

Action needed to manage climate change risks -- new report

2011-05-13
WASHINGTON — Warning that the risk of dangerous climate change impacts is growing with every ton of greenhouse gases emitted into the atmosphere, a National Research Council committee today reiterated the pressing need for substantial action to limit the magnitude of climate change and to prepare to adapt to its impacts. The nation's options for responding to the risks posed by climate change are analyzed in a new report and the final volume in America's Climate Choices, a series of studies requested by Congress. The committee that authored the report included not only ...

Existing drug treatment reduces pain in young sickle cell anemia patients

2011-05-13
DALLAS – May 12, 2011 – A cancer drug already used to treat adults and school-age children with sickle cell anemia is safe and significantly reduces pain and other complications of the disease in children as young as 9 months, according to a national study involving a UT Southwestern Medical Center researcher. Pediatric researchers at UT Southwestern and 13 other academic medical centers say hydroxyurea should be offered to all young children with sickle cell anemia, regardless of disease severity and clinical symptoms. The findings of the Pediatric Hydroxyurea in Sickle ...

LAST 30 PRESS RELEASES:

Call for papers: 14th Asia-Pacific Conference on Transportation and the Environment (APTE 2025)

A novel disturbance rejection optimal guidance method for enhancing precision landing performance of reusable rockets

New scan method unveils lung function secrets

Searching for hidden medieval stories from the island of the Sagas

Breakthrough study reveals bumetanide treatment restores early social communication in fragile X syndrome mouse model

Neuroscience leader reveals oxytocin's crucial role beyond the 'love hormone' label

Twelve questions to ask your doctor for better brain health in the new year

Microelectronics Science Research Centers to lead charge on next-generation designs and prototypes

Study identifies genetic cause for yellow nail syndrome

New drug to prevent migraine may start working right away

Good news for people with MS: COVID-19 infection not tied to worsening symptoms

Department of Energy announces $179 million for Microelectronics Science Research Centers

Human-related activities continue to threaten global climate and productivity

Public shows greater acceptance of RSV vaccine as vaccine hesitancy appears to have plateaued

Unraveling the power and influence of language

Gene editing tool reduces Alzheimer’s plaque precursor in mice

TNF inhibitors prevent complications in kids with Crohn's disease, recommended as first-line therapies

Twisted Edison: Bright, elliptically polarized incandescent light

Structural cell protein also directly regulates gene transcription

Breaking boundaries: Researchers isolate quantum coherence in classical light systems

Brain map clarifies neuronal connectivity behind motor function

Researchers find compromised indoor air in homes following Marshall Fire

Months after Colorado's Marshall Fire, residents of surviving homes reported health symptoms, poor air quality

Identification of chemical constituents and blood-absorbed components of Shenqi Fuzheng extract based on UPLC-triple-TOF/MS technology

'Glass fences' hinder Japanese female faculty in international research, study finds

Vector winds forecast by numerical weather prediction models still in need of optimization

New research identifies key cellular mechanism driving Alzheimer’s disease

Trends in buprenorphine dispensing among adolescents and young adults in the US

Emergency department physicians vary widely in their likelihood of hospitalizing a patient, even within the same facility

Firearm and motor vehicle pediatric deaths— intersections of age, sex, race, and ethnicity

[Press-News.org] Treating HIV-infected people with antiretrovirals significantly reduces transmission to partners
Findings result from NIH-funded international study